Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized study of COVAC COVID-19 vaccine in healthy adults
PACTR202203469339247Phase 1Not yet recruiting
- Sponsor
- Vaccine and Infectious Disease Organization
- Start
- Apr 2022
- Countries
- 1
01
Overview
Phase 1, randomised trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Vaccine and Infectious Disease Organization. Primary endpoints: Adverse events after first injection through Day 28 and Adverse events after second injection through Day 56. Planned start Apr 2022; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202203469339247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202203469339247.